Zydus Cadila seeks DCGI approval for novel oral pill to treat anaemia in kidney patients

The pill technically called hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor can be given to both patients who are on dialysis and not on dialysis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3CD2ZEY
via IFTTT